These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25405774)

  • 1. Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs.
    La Torre A; Giupponi G; Duffy D; Conca A; Catanzariti D
    Pharmacopsychiatry; 2015 Jan; 48(1):1-6. PubMed ID: 25405774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual dysfunction related to psychotropic drugs: a critical review. Part III: mood stabilizers and anxiolytic drugs.
    La Torre A; Giupponi G; Duffy DM; Pompili M; Grözinger M; Kapfhammer HP; Conca A
    Pharmacopsychiatry; 2014 Jan; 47(1):1-6. PubMed ID: 24222012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs.
    La Torre A; Giupponi G; Duffy D; Conca A; Cai T; Scardigli A
    Pharmacopsychiatry; 2016 Jan; 49(1):3-13. PubMed ID: 26569417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk, drugs and erectile function--a systematic analysis.
    Baumhäkel M; Schlimmer N; Kratz M; Hackett G; Jackson G; Böhm M
    Int J Clin Pract; 2011 Mar; 65(3):289-98. PubMed ID: 21314866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual dysfunction related to psychotropic drugs: a critical review part II: antipsychotics.
    La Torre A; Conca A; Duffy D; Giupponi G; Pompili M; Grözinger M
    Pharmacopsychiatry; 2013 Sep; 46(6):201-8. PubMed ID: 23737244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dysfunction related to psychotropic drugs: a critical review--part I: antidepressants.
    La Torre A; Giupponi G; Duffy D; Conca A
    Pharmacopsychiatry; 2013 Jul; 46(5):191-9. PubMed ID: 23737245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drug-associated sexual dysfunction: a prescription analysis-based study.
    al Khaja KA; Sequeira RP; al Damanhori AH; Mathur VS
    Pharmacoepidemiol Drug Saf; 2003; 12(3):203-12. PubMed ID: 12733473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual dysfunction: the 'prima ballerina' of hypertension-related quality-of-life complications.
    Manolis A; Doumas M
    J Hypertens; 2008 Nov; 26(11):2074-84. PubMed ID: 18854743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sexual side effects of pharmacological treatments].
    Giuliano F; Droupy S
    Prog Urol; 2013 Jul; 23(9):804-10. PubMed ID: 23830275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular drugs and sexuality: a cardiologist's review.
    Papadopoulos C
    Arch Intern Med; 1980 Oct; 140(10):1341-5. PubMed ID: 7425770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antihypertensive agents on sexual function.
    Weiss RJ
    Am Fam Physician; 1991 Dec; 44(6):2075-82. PubMed ID: 1684081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive treatment and sexual dysfunction.
    Manolis A; Doumas M
    Curr Hypertens Rep; 2012 Aug; 14(4):285-92. PubMed ID: 22581395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular drug use and the incidence of erectile dysfunction.
    Shiri R; Koskimäki J; Häkkinen J; Auvinen A; Tammela TL; Hakama M
    Int J Impot Res; 2007; 19(2):208-12. PubMed ID: 16900205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual function in women. Do antihypertensive drugs have an impact?
    Duncan L; Bateman DN
    Drug Saf; 1993 Mar; 8(3):225-34. PubMed ID: 8452663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric effects of cardiovascular drug therapy.
    Keller S; Frishman WH
    Cardiol Rev; 2003; 11(2):73-93. PubMed ID: 12620132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND).
    Böhm M; Baumhäkel M; Probstfield JL; Schmieder R; Yusuf S; Zhao F; Koon T;
    Am Heart J; 2007 Jul; 154(1):94-101. PubMed ID: 17584560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.